English translation of a joint press release by eight Peruvian civil society organizations. Tranlation by Justin Mendoza (Access to Medicines Organizer, Public Citizen). The original press release in Spanish is available here, and the text is reproduced below.
[CONTACT: MARLON CASTILLO – Phone: 942118412] Lima, May 25, 2017 – The Congress of the Republic’s Health Commission approved by majority vote Draft Law 275/2016-CR, which proposes to declare the medicine Atazanavir to be in the public interest. Atazanavir is used in antiretroviral therapy for people living with HIV and has cost the Peruvian government over 75 million soles over-expenditure in the past four years due to the monopoly held by the pharmaceutical company Bristol Myers Squibb for its brand-name version of the drug, known as Reyataz.